-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 29, the National Medical Security Bureau issued the Announcement
However, in some relatively "unpopular" disease areas, there are still many unmet treatment needs, and the prevention and control of cytomegalovirus infection is one of
A new preventative option
As a major innovative drug in the field of cytomegalovirus prevention and control, the new non-nucleoside cytomegalovirus inhibitor Letmovir tablets and letamovir injection have been approved to enter China
Data from key phase III clinical trials of letamovir showed that the clinically significant CMV infection rate and all-cause mortality rate at 24 weeks after transplantation were significantly reduced
Innovations are in the spotlight
This breakthrough innovation has also attracted the attention
With the continuous acceleration of the construction of "Healthy China 2030", medical innovation will provide strong support